Obstetric management of carriers of haemophilia

Haemophilia

Volumn 3, Issue 2, 1997, Pages 81-86

  Kadir, R A ^a   Economides, D L ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN;

DELIVERY; DISEASE CARRIER; FEMALE; HEMOPHILIA; HUMAN; LABOR; PRENATAL CARE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030935130     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1997.00090.x     Document Type: Review

References (48)

1. Antonarakis SE, Youssoufian H, Kazazain HH. Molecular genetics of haemophilia A in man (factor VIII deficiency) [Review]. Mol Biol Med 1987; 4: 81-94.
2. Ljung R, King S, Tedgard U. The impact of prenatal diagnosis on the incidence of haemophilia in Sweden. Haemophilia 1995; 1: 190-3.
3. Rapaport SI, Patch MJ, Moore FJ. Anti-hemophilic globulin levels in carriers of hemophilia A. J Clin Invest 1961; 39: 1619-25.
4. Rizza CR, Rhymes IL, Austen DEG, Kernoff PBA, Aronia SA. Detection of carriers of haemophilia: a "blind" study. Br J Haematol 1975; 30: 447-56.
5. Lyon MF. Sex chromatin and gene action in the mammalian x-chromosome. Am J Hum Genet 1962; 14: 135-48.
6. Lusher JM, McMillan CW. Severe factor VIII and factor IX deficiency in females. Am J Med 1978; 65: 637-48.
7. Graham JB, Barrow ES, Roberts HR, et al. Dominant inheritance of haemophilia A in three generations of women. Blood 1975; 46: 175-88.
8. Mori PG, Pasino M, Vadala CR, Bisogni MC, Tonini GP, Scarabicchi S. Haemophilia 'A' in a 46,X,i(Xq) female. Br J Haematol 1979; 43: 143-7.
9. Neuscatz J, Necheles TF. Hemophilia B in a phenotypically normal girl with XX (ring) XO mosaicism. Acta Haematol 1973; 49: 108-13.
10. Miller CH, Hilgartner MW, Aledort LM. Reproductive choices in hemophilic men and carriers. Am J Med Genet 1987; 26: 591-8.
11. Peake IR, Lillicrap DP, Boulyjenkov V, et al. Haemophilia: strategies for carrier detection and prenatal diagnosis. Bull World Health Organ 1993; 71: 429-58.
12. Oberle I, Camerino G, Heilig R, et al. Genetic screening for hemophilia A (classic haemophilia) with a polymorphic DNA probe. N Engl J Med 1985; 312: 682-6.
13. Kogan SC, Doherty M, Gitschier J. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. N Engl J Med 1987; 317: 985-90.
14. Bowen DJ, Thomas P, Webb CE, Bgnell P, Peake IR, Bloom AL. Facile and rapid analysis of three DNA polymorphism within the human factor IX gene using the polymerase chain reaction. Br J Haematol 1991; 77: 559-60.
15. Higuchi M, Antonarakis SE, Kasch L, et al. Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 1991; 88: 8307-11.
16. Higuchi M, Kazazian HH, Kasch L, et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci USA 1991; 88: 7405-9.
17. Mibashan RS, Rodeck CH, Thumpston JK, et al. Plasma assay of factor VIIIC and IX for prenatal diagnosis of haemophilia. Lancet 1979; I: 1309-11.
18. Frishein SI, Hoyer LW, Lazarchick J, et al. Prenatal diagnosis of classic hemophilia. N Engl J Med 1979; 300: 937-41.
19. Sampietro M, Camerino G, Romano M, et al. Combined use of DNA probes in first trimester prenatal diagnosis of haemophilia A. Thromb Haemost 1987; 58: 988-92.
20. Koerper MA. Prenatal diagnosis of hemophilia in the United States. Prog Clin Biol Res 1990; 324: 13-7.
21. Plattner G, Renner W, Went J, Beaudette K, Vain G. Feta sex determination by ultrasound scan in the second and third trimesters. Obstet Gynecol 1983; 61: 454-8.
22. Bronshtein M, Rottem S, Yoffe N, Bumenfeld Z, Brandes JM. Early determination of fetal sex using transvaginal sonography: technique and pitfalls. J Clin Ultrasound 1990; 18: 302-6.
23. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989; 320: 609-17.
24. Firth HV, Boyd PA, Chamberlin PF, Mackenzie IZ, Morris-Kay GM, Huson SM. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 1994; 343: 1067-71.
25. Froster UG, Jackson L. Limb defects and chorionic villus sampling: results from an international registry, 1992-94. Lancet 1996; 347: 489-94.
26. Wilson RD, Farquharson DF, Wittmann BK, Shaw D. Cordocentesis: overall pregnancy loss rate as important as procedure loss rate. Fetal Diagn Ther 1994; 9: 142-8.
27. Ljung R, Tedgard U, McNeil T, Tedgard E. How do carriers of hemophilia experience prenatal diagnosis by fetal blood sampling? Clin Genet 1987; 31: 297-302.
28. Varekamp I, Suurmeijer TP, Brocker-Vriends AH, et al Carrier testing and prenatal diagnosis for hemophilia: experiences and attitudes of 549 potential and obligate carriers. Am J Med Genet 1990; 37: 147-54.
29. Ranta S, Lehesjoki AE, Peippo M, Kaariainen H. Haemophilia A: experiences and attitudes of mothers, sisters, and daughters. Pediatr Hemtol Oncol 1994; 11: 387-97.
30. Kadir RA, Economides DL, Braithwaite J, Goldman E, Lee CA. The obstetric experience of carriers of haemophilia. Br J Obstet Gynaecol (in press).
31. Kasper CK, Hoag MS, Aggeler PM, Stoue S. Blood clotting factors in pregnancy: factor VIII concentrations in normal and AHF-deficient women. Obstet Gynaecol 1964; 24: 242-7.
32. Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-82.
33. Greer IA, Lowe GDO, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-18.
34. Briet E, Reisner HM, Blatt PM. Factor IX levels during pregnancy in a woman with hemophilia B. Haemostasis 1982; 11: 87-9.
35. Mannucci PM, Canciani MT, Rota L, Donovan BS. Response of factor VIII/V on Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and Von Willebrand's disease. Br J Haematol 1981; 47: 283-93.
36. Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449-55.
37. Burrow GN, Wassenaar W, Robertson GL, Sehl H. DDAVP treatment of diabetes insipidus during pregnancy and the post-partum period. Acta Endocrinol 1981; 97: 23-5.
38. Magner A, Aronson DL. Toxicity of factor IX concentrates in mice. Dev Biol Stand 1979; 44: 185-8.
39. Lusher JM. Thrombogenicity associated with factor IX complex concentrates. Semin Haematol 1991; 28 (Suppl. 6): 3-5.
40. Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M. Eliminating parvovirus B19 from blood products [Letter]. Lancet 1994; 343: 798.
41. Ljung R, Lindgren AC, Petrini P, Tengborn L. Normal vaginal delivery is to be recommended for haemophilia carrier gravidae. Acta Paediatr 1994; 83: 609-11.
42. Kletzel M, Miller CH, Becton DL, Chadduck WM, Elser JM. Postdelivery head bleeding in hemophilic neonates. Am J Dis Child 1989; 143: 1107-10.
43. Sage DJ. Epidurals, spinals and bleeding disorders in pregnancy: review. Anaesth Intens Care 1990; 18: 319-26.
44. Mauser Bunschoten MEP, van Houwelingen JC, Sjamsoedin Visser EJM, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of Hemophilia A and B. Thromb Haemost 1988; 59: 349-52.
45. Cunningham FG, MacDonald PC, Gant NF. Abnormalities of the third stage of labor. In: Cunningham FG, MacDonald PC, Gant NF, eds. Williams Obstetrics, 18th edn. London: Prentice-Hall, 1989: 415-24.
46. Lee CY, Madrazo B, Drukker BH. Ultrasonic evaluation of postpartum uterus in the management of postpartum bleeding. Obstet Gynecol 1981; 58: 227-32.
47. Walker ID, Walker JJ, Colvin BT, Letesky EA, Rivers R, Stevens R (on behalf of the Haemostasis and Thrombosis Task Force). Investigation and management of haemorrhagic disorders in pregnancy. J Clin Pathol 1994; 47: 100-8.
48. Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med 1966; 275: 524-8.